North America Leads the Way: Mapping the Global Consumption Patterns for CGRP Therapies
The consumption of CGRP inhibitor therapies demonstrates distinct geographical patterns, reflecting varying levels of healthcare spending, regulatory speed, and patient awareness across continents. North America, specifically the United States, holds the largest position in global consumption. This dominance is driven by several key factors: a high prevalence of diagnosed migraine, a robust...
0 Comments 0 Shares 33 Views 0 Reviews